Matthew Koopmann
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Matthew Koopmann has a total of 149 co-authors. Here are the top co-authors by number of shared publications:
Jerry J. Kim
Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA
7 shared publications- Christian de Virgilio
Department of Surgery, Harbor-UCLA Medical Center, Torrance, California
4 shared publications - Dennis Y. Kim
Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA
4 shared publications Ezinne J. Ihenachor
The David Geffen School of Medicine at UCLA, Los Angeles, CA
4 shared publicationsBrant Putnam
Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA
3 shared publicationsChristian DeVirgilio
Department of Surgery, Harbor-UCLA Medical Center, Torrance, CA
3 shared publications
Latest Publications
- 3 February 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (6) , 1595-1604
Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis
- 3 February 2026
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 83 (6) , 1595-1604
Relationship between age and the comparative outcomes of revascularization procedures in the BEST-CLI trial: A spline model analysis
- Top Cited Papers
- 15 January 2026
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 394 (3) , 219-231
Medical Management and Revascularization for Asymptomatic Carotid Stenosis
Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to intensive medical management would provide greater benefit than intensive medical management alone is unclear. We conducted two parallel, observer-blinded clinical trials that enrolled patients with high-grade (≥70%) asymptomatic carotid stenosis across 155 centers in five countries. The stenting trial compared intensive medical management alone (medical-therapy group) with carotid-artery stenting plus intensive medical management (stenting group); the endarterectomy trial compared intensive medical management alone (medical-therapy group) with carotid endarterectomy plus intensive medical management (endarterectomy group). The primary outcome was a composite of any stroke or death, assessed from randomization to 44 days, or ipsilateral ischemic stroke, assessed during the remaining follow-up period up to 4 years. A total of 1245 patients underwent randomization in the stenting trial and 1240 in the endarterectomy trial. In the stenting trial, the 4-year incidence of primary-outcome events was 6.0% (95% confidence interval [CI], 3.8 to 8.3) in the medical-therapy group and 2.8% (95% CI, 1.5 to 4.3) in the stenting group (P = 0.02 for the absolute difference). In the endarterectomy trial, the 4-year incidence of primary-outcome events was 5.3% (95% CI, 3.3 to 7.4) in the medical-therapy group and 3.7% (95% CI, 2.1 to 5.5) in the endarterectomy group (P = 0.24 for the absolute difference). From day 0 to 44, in the stenting trial, no strokes or deaths occurred in the medical-therapy group and seven strokes and one death occurred in the stenting group; in the endarterectomy trial, three strokes occurred in the medical-therapy group and nine strokes occurred in the endarterectomy group. Among patients with high-grade stenosis without recent symptoms, the addition of stenting led to a lower risk of a composite of perioperative stroke or death or ipsilateral stroke within 4 years than intensive medical management alone. Carotid endarterectomy did not lead to a significant benefit. (Funded by the National Institute of Neurological Disorders and Stroke and others; CREST-2 ClinicalTrials.gov number, NCT02089217.).
- 15 January 2026
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 394 (3) , 219-231
Top Cited PapersMedical Management and Revascularization for Asymptomatic Carotid Stenosis
Improvements in medical therapy, carotid-artery stenting, and carotid endarterectomy call into question the preferred management of asymptomatic carotid stenosis. Whether adding revascularization to intensive medical management would provide greater benefit than intensive medical management alone is unclear. We conducted two parallel, observer-blinded clinical trials that enrolled patients with high-grade (≥70%) asymptomatic carotid stenosis across 155 centers in five countries. The stenting trial compared intensive medical management alone (medical-therapy group) with carotid-artery stenting plus intensive medical management (stenting group); the endarterectomy trial compared intensive medical management alone (medical-therapy group) with carotid endarterectomy plus intensive medical management (endarterectomy group). The primary outcome was a composite of any stroke or death, assessed from randomization to 44 days, or ipsilateral ischemic stroke, assessed during the remaining follow-up period up to 4 years. A total of 1245 patients underwent randomization in the stenting trial and 1240 in the endarterectomy trial. In the stenting trial, the 4-year incidence of primary-outcome events was 6.0% (95% confidence interval [CI], 3.8 to 8.3) in the medical-therapy group and 2.8% (95% CI, 1.5 to 4.3) in the stenting group (P = 0.02 for the absolute difference). In the endarterectomy trial, the 4-year incidence of primary-outcome events was 5.3% (95% CI, 3.3 to 7.4) in the medical-therapy group and 3.7% (95% CI, 2.1 to 5.5) in the endarterectomy group (P = 0.24 for the absolute difference). From day 0 to 44, in the stenting trial, no strokes or deaths occurred in the medical-therapy group and seven strokes and one death occurred in the stenting group; in the endarterectomy trial, three strokes occurred in the medical-therapy group and nine strokes occurred in the endarterectomy group. Among patients with high-grade stenosis without recent symptoms, the addition of stenting led to a lower risk of a composite of perioperative stroke or death or ipsilateral stroke within 4 years than intensive medical management alone. Carotid endarterectomy did not lead to a significant benefit. (Funded by the National Institute of Neurological Disorders and Stroke and others; CREST-2 ClinicalTrials.gov number, NCT02089217.).
- 4 November 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 524-530
Operative and Rehabilitation Outcomes After Transfemoral Amputation With or Without Adductor Myodesis
- 4 November 2025
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 123, 524-530
Operative and Rehabilitation Outcomes After Transfemoral Amputation With or Without Adductor Myodesis
- 18 April 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (1-2) , e428-e432
Secondary Limb-Salvage Fifty Years After Vascular Injury: A Case Report
A 73-year-old veteran presented to vascular surgery with a nonhealing left lower leg wound. Fifty years before the presentation, he sustained a gunshot wound to the left leg during combat. Emergent superficial femoral artery to popliteal artery bypass using vein graft and complex bone and soft-tissue repair resulted in successful primary limb salvage. He was entered into the Vietnam Vascular Registry at the time of his initial injury. On current presentation, he was diagnosed with infected myositis ossificans and bypass occlusion. He was originally offered wound care alone with possible amputation but elected for secondary limb-salvage after vascular surgery evaluation. He underwent serial radical debridement of his myositis ossificans and revision of the left superficial femoral artery -popliteal artery bypass with reverse great saphenous vein graft. Soft-tissue reconstruction was successful with dermal replacement followed by split-thickness skin grafting. He has continued assisted primary bypass patency with satisfactory wound healing and a functional limb.
- 18 April 2025
- Published by Oxford University Press (OUP) in Military Medicine
- Vol. 191 (1-2) , e428-e432
Secondary Limb-Salvage Fifty Years After Vascular Injury: A Case Report
A 73-year-old veteran presented to vascular surgery with a nonhealing left lower leg wound. Fifty years before the presentation, he sustained a gunshot wound to the left leg during combat. Emergent superficial femoral artery to popliteal artery bypass using vein graft and complex bone and soft-tissue repair resulted in successful primary limb salvage. He was entered into the Vietnam Vascular Registry at the time of his initial injury. On current presentation, he was diagnosed with infected myositis ossificans and bypass occlusion. He was originally offered wound care alone with possible amputation but elected for secondary limb-salvage after vascular surgery evaluation. He underwent serial radical debridement of his myositis ossificans and revision of the left superficial femoral artery -popliteal artery bypass with reverse great saphenous vein graft. Soft-tissue reconstruction was successful with dermal replacement followed by split-thickness skin grafting. He has continued assisted primary bypass patency with satisfactory wound healing and a functional limb.
- Top Cited Papers
- 22 December 2022
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 387 (25) , 2305-2316
Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia
Patients with chronic limb-threatening ischemia (CLTI) require revascularization to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an initial strategy of endovascular therapy or surgical revascularization for CLTI is superior for improving limb outcomes.
- 22 December 2022
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 387 (25) , 2305-2316
Top Cited PapersSurgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia
Patients with chronic limb-threatening ischemia (CLTI) require revascularization to improve limb perfusion and thereby limit the risk of amputation. It is uncertain whether an initial strategy of endovascular therapy or surgical revascularization for CLTI is superior for improving limb outcomes.
- 21 March 2017
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 42, 32-38
Significance of Blunted Venous Waveforms Seen on Upper Extremity Ultrasound
- 21 March 2017
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 42, 32-38
Significance of Blunted Venous Waveforms Seen on Upper Extremity Ultrasound
- 1 August 2016
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 64 (2) , 547
The Modified Allen Test Is Not a Useful Tool for Assessing Palmar Arch Patency
- 1 August 2016
- Published by Elsevier in Journal of Vascular Surgery
- Vol. 64 (2) , 547
The Modified Allen Test Is Not a Useful Tool for Assessing Palmar Arch Patency
- 1 July 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 34, 45
Significance of Blunted Venous Waveforms Seen on Upper Extremity Ultrasound
- 1 July 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 34, 45
Significance of Blunted Venous Waveforms Seen on Upper Extremity Ultrasound
- 1 May 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 83-87
Factors Associated with Amputation after Popliteal Vascular Injuries
- 1 May 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 83-87
Factors Associated with Amputation after Popliteal Vascular Injuries
- 1 May 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 94-97
Vascular Trauma Operative Experience is Inadequate in General Surgery Programs
- 1 May 2016
- Published by Elsevier in Annals of Vascular Surgery
- Vol. 33, 94-97
Vascular Trauma Operative Experience is Inadequate in General Surgery Programs